UnitedHealth Group (NYSE:UNH) PT Lowered to $555.00

UnitedHealth Group (NYSE:UNH) had its target price decreased by analysts at Royal Bank of Canada from $596.00 to $555.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Royal Bank of Canada’s target price indicates a potential upside of 12.54% from the stock’s current price.

UNH has been the subject of a number of other research reports. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research report on Friday, April 5th. Truist Financial reissued a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $569.68.

UnitedHealth Group Stock Up 3.0 %

Shares of NYSE:UNH opened at $493.16 on Wednesday. The company has a market cap of $454.66 billion, a price-to-earnings ratio of 30.14, a PEG ratio of 1.28 and a beta of 0.54. UnitedHealth Group has a one year low of $436.38 and a one year high of $554.70. The firm has a fifty day moving average price of $488.97 and a two-hundred day moving average price of $515.22. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the firm posted $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group will post 27.75 EPS for the current fiscal year.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Axiom Financial Strategies LLC bought a new stake in UnitedHealth Group during the 1st quarter worth approximately $210,000. McGowan Group Asset Management Inc. boosted its stake in UnitedHealth Group by 8.9% during the first quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 61 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock worth $127,592,000 after acquiring an additional 60,300 shares during the last quarter. MAS Advisors LLC boosted its position in shares of UnitedHealth Group by 10.8% during the 1st quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock valued at $241,000 after acquiring an additional 45 shares during the last quarter. Finally, First Western Trust Bank bought a new stake in UnitedHealth Group in the first quarter worth $875,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.